Showing results (41-50 of 1,097) with videos related to
Sort By:
Pageof 110
Muscle & Nerve|April 24, 2001
Parameters for monitoring treatment effects in CIDP with anti-MAG/SGPG IgM antibodyY Tagawa, N Yuki, A Ohnishi, et al.European Neurology|June 23, 2005
Side effects of combined therapy of methylprednisolone and intravenous immunoglobulin in Guillain-Barré syndromeM Odaka, M Tatsumoto, E Hoshiyama, et al.Neurology|September 16, 2005
Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndromeM Koga, M Takahashi, M Masuda, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2005
Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporinM Odaka, M Tatsumoto, K Susuki, et al.Neurology|June 9, 2004
Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degenerationY Nishimoto, M Koga, M Kamijo, et al.Journal of Neuroimmunology|July 9, 1998
Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome?M Koga, N Yuki, T Ariga, et al.Neurology|March 24, 2004
Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicryK Susuki, M Odaka, M Mori, et al.Journal of the Neurological Sciences|May 1, 1999
Are Campylobacter curvus and Campylobacter upsaliensis antecedent infectious agents in Guillain-Barré and Fisher's syndromes?M Koga, N Yuki, M Takahashi, et al.Journal of the Neurological Sciences|June 1, 2000
Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapyM Odaka, N Yuki, E Nobile-Orazio, et al.Journal of the Neurological Sciences|August 18, 1999
Antibodies to GD1alpha and to GQ1beta in Guillain-Barré syndrome and the related disordersM Odaka, N Yuki, H Yoshino, et al.Pageof 110